Hyesun “Sunny” Jang

Hyesun “Sunny” Jang, PhD, DVM

Staff Scientist

Bio

Hyesun “Sunny” Jang is a staff scientist at the J. Craig Venter Institute, supervised by Dr. Marcelo Freire. With a background as a veterinarian, Dr. Jang is interested in developing host-directed anti-viral strategies against diverse zoonotic viruses.

Dr. Jang received her doctor of veterinary medicine (DVM) and master of science (MS) degrees from Chungbuk National University in South Korea (2005-2012). During the eight-year-training in Korea, Dr. Jang focused on developing novel strategies to diagnose and control avian diseases. In 2013, Dr. Jang moved to United States to pursue a PhD at Ohio State University (2013-2017) followed by postdoctoral training at the University of Georgia (2018-2021). During her PhD and postdoctoral training, Dr. Jang’s research interests led her to apply her knowledge of host-pathogen interactions to improve vaccines against zoonotic avian influenza viruses.

With her expertise in virology and veterinary medicine, she has been actively engaged in diverse projects to evaluate candidate prophylactics/therapeutics against the novel SARS-CoV-2 virus. Dr. Jang has also collaborated with pioneers in a wide range of fields, inspiring her to expand her research to include high-throughput analysis on biofluids. Dr. Jang joined JCVI to apply omics tools in the investigation of host-pathogen interactions. She believes that a better understanding of host-pathogen interaction will lead to the development of innovative prophylactic/therapeutic measures against rapidly evolving zoonotic viruses.

Publications

Publications

Frontiers in immunology. 2023-10-19; 14.1220610.

Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses

Jang H, Matsuoka M, Freire M
PMID: 37928529

Cell. 2021-04-01; 184.7: 1821-1835.e16.

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, Manenti A, Pantano E, Kabanova A, Troisi M, Vacca F, Cardamone D, De Santi C, Torres JL, Ozorowski G, Benincasa L, Jang H, Di Genova C, Depau L, Brunetti J, Agrati C, Capobianchi MR, Castilletti C, Emiliozzi A, Fabbiani M, Montagnani F, Bracci L, Sautto G, Ross TM, Montomoli E, Temperton N, Ward AB, Sala C, Ippolito G, Rappuoli R
PMID: 33667349

Cell. 2021-04-01; 184.7: 1804-1820.e16.

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE, Diamond MS
PMID: 33691139

Poultry science. 2021-03-01; 100.3: 100893.

Prevalence, biosecurity factor, and antimicrobial susceptibility analysis of Salmonella species isolated from commercial duck farms in Korea

Kim TS, Kim GS, Son JS, Lai VD, Mo IP, Jang H
PMID: 33518320

Veterinary microbiology. 2020-12-01; 251.108907.

Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h

Jang H, Ross TM
PMID: 33129043

Human vaccines & immunotherapeutics. 2020-09-01; 16.9: 2042-2050.

Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge

Jang H, Meyers LM, Boyle C, De Groot AS, Moise L, Ross TM
PMID: 32783766

Expert review of vaccines. 2019-10-11; 18.10: 1043-1051.

Preexisting influenza specific immunity and vaccine effectiveness

Jang H, Ross TM
PMID: 31575308

PloS one. 2018-04-06; 13.4: e0195285.

Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens

Jang H, Elaish M, Kc M, Abundo MC, Ghorbani A, Ngunjiri JM, Lee CW
PMID: 29624615